GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
2,371
Funds Holding Change
+28
Funds Holding Growth
+1%
Value
$429B
Holding in Top 10
540
Top 10 Change
+75
Top 10 Growth
+16%
Value Growth
+8%
New
115
Increased
1,059
Reduced
1,037
Closed
63
Capital Inflow
$17.8B
Capital Outflow
$16.6B
Net Capital Flow
+$1.23B
Capital Flow Change
+$4.55B
Calls
$6.72B
Puts
$5.91B
Net Calls
+$811M
Put/Call Ratio
0.88